Skip to Content

'
Surena F. Matin, M.D.

Present Title & Affiliation

Primary Appointment

Professor, Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1994 Cornell Univ. Medical College, New York, NY, MD, Doctor of Medicine
1990 Old Dominion University, Norfolk, VA, BS, Summa Cum Laude, Biology, English Minor

Postgraduate Training

2001-2002 Clinical Fellowship, Laparoscopy and Endourology Fellowship, Cleveland Clinic Foundation, Cleveland, OH, Inderbir S. Gill, M.D. and Stevan B. Streem, M.D.
2000-2001 Research Fellowship, Tumor Immunology, Cleveland Clinic Foundation, Cleveland, OH, James A. Finke, Ph.D.
1995-2000 Clinical Residency, Urology, Cleveland Clinic Foundation, Cleveland, OH, Drogo K. Montague, M.D.
1994-1995 Clinical Internship, General Surgery, Cleveland Clinic Foundation, Cleveland, OH, Frederick Alexander, M.D.

Board Certifications

2/2011 American Board of Urology

Experience/Service

Academic Appointments

Associate Professor, Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 9/2007-8/2013
Assistant Professor, Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 7/2002-8/2007
Clinical Associate, Department of Urology, Division of Surgery, Cleveland Clinic Foundation, Cleveland, OH, 7/2000-6/2002

Administrative Appointments/Responsibilities

Medical Director, Minimally Invasive and New Technology in Oncologic Surgery (MINTOS) Collaborative Group, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006-present

Other Appointments/Responsibilities

Abstract Reviewer, The American Urological Association, San Diego, CA, 5/2013
Abstract Reviewer, The American Urological Association, San Diego, CA, 5/2012
Urology Representative for Barretos Cancer Hospital (Barretos. Brazil), Global Academic Programs, U.T. MD Anderson Cancer Center, Barretos, 11/2010-present
Executive Committee, Kidney Cancer Multidisciplinary Research Program, UT MD Anderson Cancer Center, Houston, TX, 1/2010-present
Member, Faculty Promotion and Tenure Committee, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2008-2011
Member, Surgical Education Subcommittee, Cleveland Clinic Foundation, Columbus, OH, 1998-2000

Honors and Awards

2013 SUO Young Investigator Award, Society of Urologic Oncology
2010 Scholar, Academic Fellowship Exchange, Urological Association /European Association of Urology
2009 Health and Science Communications Association, Gold Award,Robotic Radical Prostatectomy Patient Informed Consent and Education Video
2008 National Health Information Award, Silver Medal, Robotic Radical Prostatectomy Patient Informed Consent and Education Video
2004-2005 Excellence in Teaching Award, Biomedical Engineering Summer Internship Program, The University of Texas M. D. Anderson Cancer Center
2003 Best Video in Urology Category, American Society for Reproductive Medicine, "Robotic-Assisted Vasovasostomy: A Pilot Study"
2001-2002 Scholars in Urology Award, Pfizer
2000-2001 Scholar, American Foundation for Urologic Disease
2000 Bruce H. Stewart Award for Humanistic Medicine, Cleveland Clinic Foundation
1986-1990 Dominion Scholar, Old Dominion University

Selected Publications

Peer-Reviewed Original Research Articles

1. Abel EJ, Karam JA, Carrasco A, Matin SF. Laparoscopic adrenalectomy for metachronous metastases after ipsilateral nephrectomy for renal-cell carcinoma. J Endourol 25(8):1323-7, 8/2011.
2. Abel EJ, Culp SH, Tannir NM, Matin SF, Tamboli P, Jonasch E, Wood CG. Primary tumor response to targeted therapy in patients with metastatic renal cell carcinioma: practical implications for timing of pre-surgical therapy. European Urology 59(1):10-15, 1/2011.
3. Abel EJ, Culp SH, Matin SF, Tamboli P, Wallace MJ, Jonasch E, Tannir NM, Wood CG. Percutaneous biopsy of primary tumor in metastatic renal cell carcinoma to predict high risk pathological features: Comparison with nephrectomy assessment. J Urol 184(5):1877-1881, 11/2010. e-Pub 9/2010. PMID: 20850148.
4. Karam JA, Ahrar K, Wood CG, Jonasch E, Vikram R, Romero C, Tannir N, Matin SF. Radiofrequency ablation of renal tumors in patients with metastatic renal cell carcinoma. J Urology 184(5):1882-1887, 11/2010. e-Pub 9/2010. PMID: 20846689.
5. Matin SF, Kamat A, Grossman HB. High frequency endoluminal ultrasonography for as an aid to the staging of upper tract urothelial carcinoma: imaging findings and pathologic correlation. J Ultrasound in Medicine 29(9):1277-1284, 9/2010. PMID: 20733182.
6. Culp SH, Tannir NM, Abel EJ, Margulis V, Tamboli P, Matin SF, Wood CG. Can we better select patients with metastatic renal cell carcinoma for cytoreductive nephrectomy? Cancer 116(14):3378-3388, 7/2010. PMID: 20564061.
7. Matin SF, Kamat AK, Wood CG, Grossman HB, Brown GA, Dinney CPN, Millikan R, Siefker-Radtke AO. Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma. Cancer 116(13):3127-3134, 7/2010.
8. Childs MA, Wood CG, Spiess PE, Debiane LG, Hernandez M, Matin SF, Millikan RE, Siefker-Radtkie A, Scott SM, Pisters LL. Early results of chemotherapy with retroperitoneal lymph node dissection for isolated retroperitoneal recurrence of upper urinary tract urothelial carcinoma after nephroureterectomy. Canadian Journal of Urology 17(3):5184-5189, 6/2010.
9. Hoang AN, Vaporcyian AA, Matin SF. Laparoscopy-assisted radical nephrectomy with inferior vena caval thrombectomy for level II to III tumor thrombus: a single-institution experience and review of the literature. J Endourol 24(6):1005-12, 6/2010. PMID: 20491594.
10. Shikanov S, Lifshitz D, Chan AA, Okhunov Z, Ordonez A, Wheat JC, Matin SF, Landman J, Wolf Jr S, Eggener SE,Shalhav AL. Impact of ischemia on renal function laparoscopic partial nephrectomy: A multicenter study. Journal of Urology 183(5):1714-1718, 5/2010.
11. Chan A, Wood CG, Caicedo J,Munsell MF, Matin SF. Predictors of unilateral renal function after open and laparoscopic partial nephrectomy. Urology 75(2):295-302, 2/2010. PMID: 19963245.
12. Svatek RS, Fisher MB, Matin SF, Kamat AM, Grossman HB, Nogueras-Gonzalez GM, Urbauer DL, Kennedy KA, Dinney CP. Risk factor analysis in a contemporary cystectomy cohort using standardized reporting methodology and adverse event criteria. J Urol 183(3):929-934, 1/2010.
13. Javadi S, Ahrar JU, Ninan E, Gupta NE, Matin SF, Ahrar K. Characterization of contrast enhancement in the ablation zone immediately after radiofrequency ablation of renal tumors. Journal of Vascular & Interventional Radiology 21(5):690-695, 2010.
14. Abel EJ, Culp SH, Meissner M, Matin SF, Tamboli P, Wood CG. Identifying the risk for disease progression after surgery for localized renal cell carcinoma. BJU International 106(9):1277-1283, 2010. e-Pub 4/2010. PMID: 20394619.
15. Matin SF, Sharma P, Gill IS, Tannenbaum C, Hobart MG, Novick AC, Finke JH. Immunological response to renal cryoablation in an in vivo orthotopic renal cell carcinoma murine model. J Urol 183(1):333-338, 2010.
16. Chiong E, Hegarty PK, Davis JW, Kamat AM, Pisters LL, Matin SF. Port-site hernias occuring after the use of bladeless radially expanding trocars. Urology 75:574-580, 2010. PMID: 19854489.
17. Raman JD, Raj GV, Lucas SM, Williams SK, Lauer EM, Ahrar K, Matin SF, Leveillee RJ, Cadeddu JA. Renal function outcomes for tumours in a solitary kidney managed by ablative or extirpative techniques. BJU International 105(4):496-500, 2010.
18. Fisher M, Svatek R, Hegarty PK, McGinnis JE, Hightower C, Grossman HB, Kamat AM, Dinney CPN, Matin SF. Cardiac history and risk of post-cystectomy cardiac complication. Urology, 9/2009.
19. Jonasch E, Wood CG, Matin SF, Tu SM, Pagliaro LC, Corn PG, Aparicio A, Tamboli P, Millikan RE, Wang X, Araujo JC, Arap W, Tannir N. Phase II presurgical feasibility study of bevacizumab in untreated patients with metastatic renal cell carcinoma. J Clin Oncol. 27(25):4076-4081, 9/2009. e-Pub 7/2009.
20. Clague J, Lin J, Cassidy A, Matin SF, Tannir N, Tamboli P, Wood C, Wu X. Family history and risk of renal cell carcinoma: results from a case-control study and systematic meta-analysis. Cancer Epidemiology, Biomarkers and Prevention 18(3):801-807, 3/2009.
21. Margulis V, Matin SF, Tannir N, Tamboli P, Shen Y, Lozano M, Swanson DA, Jonasch E, Wood CG. A randomized trial of adjuvant thalidomide versus observation in patients with completely resected high risk cell carcinoma. Journal of Urology 73(2):337-341, 2/2009.
22. Campbell SC, Novick AC, Belldegrun A, Blute ML, Chow GK, Derweesh IH, Faraday MM, Kaouk JH, Leveillee RJ, Matin SF, Russo P, Uzzo RG. Guideline for management of the clinical T1 renal mass. Journal of Urology 182(4):1271-1279, 2009.
23. Davis JW, Kamat AM, Munsell MF, Pettaway CA, Pisters LL, Matin SF. Initial experience of teaching robot-assisted radical prostatectomy to surgeons-in-training: Can training be evaluated and standardized? BJU Int 105(8):1148-1154, 2009.
24. Matin SF, Feeley T, Kennamer D, Corriere J, Miles M, Kays C,Green H, Craig C, Dinney C. Office cystoscopy and transrectal ultrasound-guided prostate biopsies pose minimal risk: A prospective evaluation of 921 procedures. Urology 73(6):1175-1178, 2009.
25. Shah SK, Matin SF, Singer EA, Eichel L, Kim HL. Outcomes of laparoscopic partial nephrectomy after fellowship training. Journal of the Society of Laparoendoscopc Surgeons 13(2):154-159, 2009.
26. Zorn C, Gautam G, Shalhav L, Clayman V, Ahlering E, Albala M, Lee I, Sundaram P, Matin SF, Castle P, Winfield N, Samadi G, Gettman T, Lee R, Thomas R, Patel R, Leveillee J, Wong C, Badlani H, Rha H, Eggener E, Joseph V, Members of the Society of Urologic Robotic Surgeons (SURS) Committee. Training, credentialing, proctoring and medicolegal risks of robotic urological surgery: Recommendations of the Society of Urologic Robotic Surgeons (SURS). J Urol 182:1126-1132, 2009.
27. Lin J, Pu X, Wang W, Matin SF, Tannir NM, Wood CG, Wu X. Case-control analysis of nucleotide excision repair pathway and the risk of renal cell carcinoma carcinogenesis 29(11):2112-2119, 11/2008. e-Pub 8/2008.
28. Rich TA, Jonasch E, Matin SF, Waguespack SG, Gombos DS, Santarpia L, Stolle C, Jimenez C. A novel von Hippel-Lindau point mutation presents as apparently sporadic pheochromocytoma. Cancer Investigation 26(6):642-646, 7/2008.
29. Matin SF, Tinkey PT, Borne AT, Stephens LC, Sherz A, Swanson DA. A pilot trial of vascular targeted photodynamic therapy for renal tissue. Journal of Urology 180(1):338-342, 7/2008.
30. Margulis V, Tamboli P, Matin SF, Swanson DA, Wood CG. Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma. Cancer 112(7):1480-8, 4/2008.
31. Ponsky L, Cherullo E, Moinzadeh A, Desai M, Kaouk J, Haber GP, Chen D, Ng C, Fuchs G, Singh D, Finelli A, Matin SF. The Hem-o-lok clip is safe for laparoscopic nephrectomy: a multi-institutional review. Urology 71(4):593-6, 4/2008. e-Pub 3/2008.
32. Busby JE, Brown GA, Matin SF. Comparing lymphadenectomy during radical nephroureterectomy: open versus laparoscopic. Urology 71(3):413-6, 3/2008.
33. Jain M, Matin SF, Kamat A. Inferior vena cava atresia associated with von Hippel-Lindau masquerading as metastatic testicular cancer. Current Urology 2:214-216, 2008.
34. Sabichi L, Lerner P, Atkinson E , Grossman H, Caraway P, Dinney P, Penson F, Matin SF, Kamat A, Pisters L, Lin W, Katz L, Brenner E, Hemstreet III P, Wargo M, Bleyer A, Sanders H, Clifford L, Parnes L, Lippman M. Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer. Clin Cancer Res 14:224-229, 2008.
35. Margulis V, Matin SF, Tannir N, Tamboli P, Swanson DA, Jonasch E, Wood CG. Surgical morbidity associated with administration of targeted molecular therapies prior to cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma. Journal of Urology 180(1):94-98, 2008.
36. Shao L, Wood CG, Zhang D, Tannir NM, Matin SF, Dinney CP, Wu XF. Telomere dysfunction in peripheral lymphocytes as a potential predisposition factor for renal cancer. J Urol 178 (4):1492-1496, 2008.
37. Margulis V, Tamboli P, Matin SF, Meisner M, Swanson DA, Wood CG. Location of extrarenal tumor Extension does not impact survival of patients with pT3a renal cell carcinoma. J Urol 178(5):1878-1882, 11/2007.
38. Javadi S, Matin SF, Tamboli P, Ahrar K. Unexpected atypical findings on CT after radiofrequency ablation for small renal-cell carcinoma and the role of percutaneous biopsy. J Vasc Interv Radiol 18(9):1186-1191, 9/2007.
39. Brown GA, Matin SF, Busby JE, Dinney CP, Grossman HB, Pettaway CA, Munsell MF, Kamat AM. Ability of clinical grade to predict final pathologic stage in upper urinary tract transitional cell carcinoma: implications for therapy. Urology 70(2):252-256, 7/2007.
40. Shao L, Wood CG, Zhang D, Tannir NM, Matin SF, Dinney CP, Wu X. Telomere dysfunction in peripheral lymphocytes as a potential predisposition factor for renal cancer. J Urol 178(4):1186-1191, 7/2007.
41. Kassouf W, Sanchez-Ortiz R, Tamboli P, Tannir N, Jonasch E, Merchant MM, Matin SF, Swanson DA, Wood CG. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclea cell histology. J Urol 69(5):819-823, 3/2007.
42. Black PC, Basen-Engquist K, Wang X, Swartz RJ, Eddings T, Matin SF, Swanson D, Wood CG, Pisters LL, Babaian RJ, Troncoso P, Pettaway CA. A randomized prospective trial evaluating testosterone, haemoglobin kinetics and quality of life, during and after 12 months of androgen deprivation after prostatectomy: results from the Postoperative Adjuvant Androgen Deprivation trial. BJU Int 100(1):63-9, 2007.
43. Kader AK, Tamboli P, Luongo T, Matin SF, Bell K, Jonasch E, Swanson DA, Wood CG. Cytoreductive neprectomy in the elderly patient: the M.D. Anderson Cancer Center experience. J Urol 177(3):855-861, 2007.
44. Jacobsohn KM, Ahrar K, Wood CG, Matin SF. Is radiofrequency ablation safe for solitary kidneys? Urology 69(5):819-823, 2007.
45. Brown GA and Matin SF. Laparoscopic partial nephrectomy: Experience in 60 cases. J Endourol 21(1):71-74, 2007.
46. Margulis V, Tamboli P, Matin SF, Meisner M, Swanson DA, Wood CG. Redefining pPT3 renal cell carcinoma in the modern era: A proposal for a revision of the current TNM primary tumor classification system. Cancer 109(2):2439-2444, 2007.
47. Brown GA, Busby JE, Wood CG, Pisters LL, Dinney CP, Swanson DA, Grossman HB, Pettaway CA, Munsell MF, Kamat AM, Matin SF. Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm? BJU Int 98:1176-1180, 12/2006. PMID: 17125474.
48. Matin SF, Dhanani N, Acosta M, Wood CG. Conventional and hand-assisted laparoscopic radical nephrectomy: Comparative analysis of 271 cases. J Endourol 20:891-894, 11/2006. PMID: 17144857.
49. Matin SF, Ahrar K, Cadeddu JA, Gervais DA, McGovern FJ, Zagoria RA, Uzzo RG, Haaga J, Resnick MI, Kaouk J, Gill IS. Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study. J Urol 176:1973-1977, 11/2006. PMID: 17070224.
50. Matin SF, Madsen LT, Wood CG. Laparoscopic cytoreductive nephrectomy: the M. D. Anderson Cancer Center experience. Urology 68:528-532, 9/2006. PMID: 16979706.
51. Matin SF. Recognition and preservation of accessory pudendal arteries during laparoscopic radical prostatectomy. Urology 67:1012-1015, 5/2006. PMID: 16635507.
52. Busby JE, Brown GA, Tamboli P, Kamat AM, Dinney CP, Grossman HB, Matin SF. Upper urinary tract tumors with nontransitional histology: a single-center experience. Urology 67(3):518-23, 3/2006. PMID: 16527570.
53. Berglund RK, Matin SF, Desai M, Kaouk J, Gill IS. Laparoscopic radical cystoprostatectomy with bilateral nephroureterectomy: initial report. BJU Int 97:37-41, 2006. PMID: 16336325.
54. Goel MC, Matin SF, Derweesh I, Levin H, Streem S, Novick AC. Partial nephrectomy for renal urothelial tumors: Clinical update. Urology 67:490-495, 2006.
55. Naude AM, Heyns CF, Matin SF. Laparoscopic urology training in South Africa. J Endourol 19:1180-1184, 12/2005. PMID: 16359210.
56. Ahrar K, Matin SF, Wallace MJ, Gupta S, Hicks ME. Percutaneous transthoracic radiofrequency ablation of renal tumors using an iatrogenic pneumothorax. AJR Am J Roentgenol 185(1):86-88, 7/2005. PMID: 15972404.
57. Cohen DD, Matin SF, Steinberg JR, Zagone R, Wood CG. Evaluation of the intact specimen after laparoscopic radical nephrectomy for clinically localized renal cell carcinoma identifies a subset of patients at increased risk for recurrence. J Urol 173(5):1487-1491, 5/2005. PMID: 15821465.
58. Highshaw RA, Vakar-Lopez F, Jonasch E, Yasko AW, Matin SF. Port-site metastasis: the influence of biology. Eur Urol 47:357-360, 3/2005. PMID: 15716201.
59. Stage AC, Pollock RE, Matin SF. Bilateral metastatic renal synovial sarcoma. Urology 65)2):389, 2/2005. PMID: 15708068.
60. Matin SF, Gill IS. Recurrence and survival following laparoscopic radical nephroureterectomy with various forms of bladder cuff control. J Urol 173:395-400, 2/2005. PMID: 15643179.
61. Ahrar K, Matin SF, Wood CG, Wallace MJ, Gupta S, Madoff DC, Rao S, Tannir NM, Jonasch E, Pisters LL, Rozner MA, Kennamer DL, Hicks ME. Percutaneous radiofrequency ablation of renal tumors: Technique, complications, and outcomes. J Vasc Interv Radiol 16(5):679-688, 2005.
62. Desai MM, Strzempkowski B, Matin SF, Steinberg AP, Ng C, Meraney AM, Kaouk JH, Gill IS. Prospective randomized comparison of transperitoneal versus retroperitoneal laparoscopic radical nephrectomy. J Urol 173(1):38-41, 2005. PMID: 15592021.
63. Kuang W, Shin PR, Matin SF, Thomas AJ, Jr. Initial evaluation of robotic technology for microsurgical vasovasostomy. J Urol 171(1):300-303, 2004. PMID: 14665899.
64. Ahrar K, Matin SF, Wood CG, Gupta S, Wallace MJ, Madoff DC. Utility of contrast-enhanced CT during percutaneous RFA of solid renal tumors. Am J Roentgenol 182(4):13, 2004.
65. Matin SF, Abreu S, Ramani A, Steinberg AP, Desai M, Strzempkowski B, Yang Y, Shen Y, Gill IS. Evaluation of age and comorbidity as risk factors after laparoscopic urological surgery. J Urol 170(4):1115-1120, 10/2003. PMID: 14501704.
66. Matin SF, Yost A, Streem SB. Ureteroscopic laser endopyelotomy: a single-center experience. J Endourol 17(6):401-404, 8/2003. PMID: 12965067.
67. Matin SF. Prospective randomized trial of skin adhesive versus sutures for closure of 217 laparoscopic port-site incisions. J Am Coll Surg 196(6):845-853, 6/2003. PMID: 12788419.
68. Matin SF, Gill IS. Modified Pfannenstiel incision for intact specimen extraction after retroperitoneoscopic renal surgery. Urology 61(4):830-832, 4/2003. PMID: 12670577.
69. Desai MM, Gill IS, Ramani AP, Matin SF, Kaouk JH, Campero JM. Laparoscopic radical nephrectomy for cancer with level I renal vein involvement. J Urol 169(2):487-491, 2/2003. PMID: 12544294.
70. Gill IS, Matin SF, Desai MM, Kaouk JH, Steinberg A, Mascha E, Thornton J, Sherief M, Strzempkowski B, Novick AC. Comparative analysis of laparoscopic and open partial nephrectomy for renal tumors in 200 patients. J Urol 170(1):64-66, 2003.
71. Bandyopadhyay SK, Rackley RR, Matin SF, Sadhukhan PC. Interferon-alpha response and signal transduction pathway in transitional carcinoma cell lines. Adv Exp Med Biol 539:15-32, 2003. PMID: 15088893.
72. Desai M, Gill IS, Kaouk JH, Matin SF, Novick AC. Laparoscopic partial nephrectomy with suture repair of the pelvicaliceal system. Urology 61(1):99-104, 2003.
73. Matin SF, Hsu TH, Klein EA, Streem SB. Acute renal failure due to subcapsular renal hematoma in a solitary kidney: improvement after decompression. J Urol 168(6):2526-2527, 12/2002. PMID: 12441956.
74. Kaouk JH, Matin SF, Bravo EL, Gill IS. Laparoscopic bilateral partial adrenalectomy for pheochromocytoma. Urology 60:1100-1103, 12/2002. PMID: 12475679.
75. Desai MM, Gill IS, Kaouk JH, Matin SF, Sung GT, Bravo EL. Robotic-assisted laparoscopic adrenalectomy. Urology 60(6):1104-1107, 12/2002. PMID: 12475680.
76. Kuang W, Ng CS, Matin SF, Kaouk JH, El-Jack M, Gill IS. Rhabdomyolysis after laparoscopic donor nephrectomy. Urology 60(5):911-912, 11/2002. PMID: 12429334.
77. Matin SF, Gill IS, Worley S, Novick AC. Outcome of laparoscopic radical and open partial nephrectomy for the sporadic 4 cm. or less renal tumor with a normal contralateral kidney. J Urol 168(4):1356-1359, 10/2002. PMID: 12352392.
78. Matin SF, Yost A, Streem SB. Extracorporeal shock-wave lithotripsy: a comparative study of electrohydraulic and electromagnetic units. J Urol 166(6):2053-2056, 12/2001. PMID: 11696705.
79. Goldfarb DA, Matin SF, Braun WE, Schreiber MJ, Mastroianni B, Papajcik D, Rolin HA, Flechner S, Goormastic M, Novick AC. Renal outcome 25 years after donor nephrectomy. J Urol 166(6):2043-2047, 12/2001. PMID: 11696703.
80. Hsu TH, Matin SF. Benign prostatic hyperplasia mimicking bladder tumor. Urology 57(6):1166, 6/2001. PMID: 11377336.
81. Matin SF, Rackley RR, Sadhukhan PC, Kim MS, Novick AC, Bandyopadhyay SK. Impaired alpha-interferon signaling in transitional cell carcinoma: lack of p48 expression in 5637 cells. Cancer Res 61(5):2261-2266, 3/2001. PMID: 11280796.
82. Matin SF, Novick AC. Renal dysfunction associated with staged bilateral partial nephrectomy: the importance of operative positioning. J Urol 165(3):880-881, 3/2001. PMID: 11176491.
83. Matin SF, Streem SB. Metabolic risk factors in patients with ureteropelvic junction obstruction and renal calculi. J Urol 163(6):1676-1678, 6/2000. PMID: 10799158.
84. Matin SF, Gill IS. Laparoscopic marsupialization of the difficult lymphocele using internalized peritoneal dialysis catheter. J Urol 163(6):1498-1500, 5/2000. PMID: 10751865.
85. Rackley RR, Bandyopadhyay SK, Matin SF, Shin MS, Appell R. Immunoregulatory potential of urothelium: characterization of NF-kappaB signal transduction. J Urol 162(5):1812-1816, 11/1999. PMID: 10524940.
86. Matin SF, Gill IS, Hsu TH, Sung GT, Novick AC. Laparoscopic renal and adrenal surgery in obese patients: comparison to open surgery. J Urol 162:665-669, 9/1999. PMID: 10458337.
87. Hsu TH, Gill IS, Matin SF, Soble JJ, Sung GT, Schweizer D, Novick AC. Radical nephrectomy and nephroureterectomy in the octogenarian and nonagenarian: comparison of laparoscopic and open approaches. Urology 53(6):1121-1125, 6/1999. PMID: 10367839.
88. Matin SF, Novick AC. Nephron-sparing surgery for renal angiomyolipoma. Urology 52(4):577-583, 10/1998. PMID: 9763074.
89. Matin SF, Montague DK, Angermeier KW, Lakin MM. Penile fracture after intracavernous injection therapy. J Urol 159(6):2094, 6/1998. PMID: 9598535.
90. Matin SF, Streem SB. Nephron sparing management of Fraley's syndrome with a pyelopyelostomy. J Urol 159(2):487-489, 2/1998. PMID: 9649268.
91. Matin SF, Rackely R, Bandyopadhyay S. Defective interferon-alpha signaling in transitional cell carcinoma. Eur Cytokine Netw 9:506-507, 1998.
92. Matin SF, Goldfarb DA, Novick AC. Upper tract surgery in pregnancy. Urology 52(3):510-511, 1998.
93. Matin SF, Levin HS, Streem SB. Ureteroscopic diagnosis of intraluminal metastatic rectal carcinoma. Urology 49(6):955-956, 1997.

Editorials

1. Matin SF. What's more important, ischemia time or parenchymal preservation? Urology. In Press.

Last updated: 8/27/2013